These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20509035)

  • 1. S100P: a novel therapeutic target for cancer.
    Arumugam T; Logsdon CD
    Amino Acids; 2011 Oct; 41(4):893-9. PubMed ID: 20509035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer.
    Onyeagucha BC; Mercado-Pimentel ME; Hutchison J; Flemington EK; Nelson MA
    Exp Cell Res; 2013 Aug; 319(13):2081-2090. PubMed ID: 23693020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.
    Jiang H; Hu H; Tong X; Jiang Q; Zhu H; Zhang S
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):1-9. PubMed ID: 21947242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100P, a peculiar member of S100 family of calcium-binding proteins implicated in cancer.
    Tóthová V; Gibadulinová A
    Acta Virol; 2013; 57(2):238-46. PubMed ID: 23600880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis.
    Arumugam T; Ramachandran V; Gomez SB; Schmidt AM; Logsdon CD
    Clin Cancer Res; 2012 Aug; 18(16):4356-64. PubMed ID: 22718861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100P promotes pancreatic cancer growth, survival, and invasion.
    Arumugam T; Simeone DM; Van Golen K; Logsdon CD
    Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.
    Mercado-Pimentel ME; Onyeagucha BC; Li Q; Pimentel AC; Jandova J; Nelson MA
    FEBS Lett; 2015 Aug; 589(18):2388-93. PubMed ID: 26193421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation and functional implication of S100P in cancer.
    Gibadulinova A; Tothova V; Pastorek J; Pastorekova S
    Amino Acids; 2011 Oct; 41(4):885-92. PubMed ID: 20155429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma.
    Zhu L; Ito T; Nakahara T; Nagae K; Fuyuno Y; Nakao M; Akahoshi M; Nakagawa R; Tu Y; Uchi H; Furue M
    J Dermatol; 2013 Dec; 40(12):973-9. PubMed ID: 24303922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
    Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
    Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular regulation of S100P in human lung adenocarcinomas.
    Rehbein G; Simm A; Hofmann HS; Silber RE; Bartling B
    Int J Mol Med; 2008 Jul; 22(1):69-77. PubMed ID: 18575778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy.
    Arumugam T; Ramachandran V; Sun D; Peng Z; Pal A; Maxwell DS; Bornmann WG; Logsdon CD
    Mol Cancer Ther; 2013 May; 12(5):654-62. PubMed ID: 23303403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways.
    Fuentes MK; Nigavekar SS; Arumugam T; Logsdon CD; Schmidt AM; Park JC; Huang EH
    Dis Colon Rectum; 2007 Aug; 50(8):1230-40. PubMed ID: 17587138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional evidence implicating S100P in prostate cancer progression.
    Basu GD; Azorsa DO; Kiefer JA; Rojas AM; Tuzmen S; Barrett MT; Trent JM; Kallioniemi O; Mousses S
    Int J Cancer; 2008 Jul; 123(2):330-339. PubMed ID: 18452169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.
    Hsu YL; Hung JY; Liang YY; Lin YS; Tsai MJ; Chou SH; Lu CY; Kuo PL
    Oncotarget; 2015 Oct; 6(30):29585-98. PubMed ID: 26320193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
    Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
    Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE).
    Arumugam T; Simeone DM; Schmidt AM; Logsdon CD
    J Biol Chem; 2004 Feb; 279(7):5059-65. PubMed ID: 14617629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-Bound S100P Protein Is a Promiscuous Binding Partner of the Four-Helical Cytokines.
    Kazakov AS; Deryusheva EI; Permyakova ME; Sokolov AS; Rastrygina VA; Uversky VN; Permyakov EA; Permyakov SE
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting S100P inhibits colon cancer growth and metastasis by Lentivirus-mediated RNA interference and proteomic analysis.
    Jiang L; Lai YK; Zhang J; Wang H; Lin MC; He ML; Kung HF
    Mol Med; 2011; 17(7-8):709-16. PubMed ID: 21327297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
    Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
    Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.